Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Director (Cincinnati, Ohio)
|
October 1, 1993
Therapeutic options in the treatment of congestive heart failure. Part I
M B Bottorff
Director (Cincinnati, Ohio)
|
January 1, 1994
Therapeutic options in the treatment of congestive heart failure. Part II
M B Bottorff
Pharmacotherapy
|
April 23, 1999
Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations
M B Bottorff, D M Tenero
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1992
Advances in antiarrhythmic drug therapy
D C Harrison, M B Bottorff
Clinical Chemistry
|
September 1, 1986
Fluorescence polarization immunoassay for ethosuximide evaluated and compared with two other immunoassay techniques
C F Stewart, M B Bottorff
Clinical Pharmacokinetics
|
December 1, 1991
Pharmacokinetic interactions with calcium channel antagonists (Part II)
K D Schlanz, S A Myre, M B Bottorff
Therapeutic Drug Monitoring
|
January 1, 1989
A high-performance liquid chromatographic method for the determination of encainide and its major metabolites in urine and serum using solid-phase extraction
D J Kazierad, T J Hoon, M B Bottorff
Pharmacotherapy
|
September 1, 1985
Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties
M B Bottorff, D R Rutledge, J A Pieper
Therapeutic Drug Monitoring
|
January 1, 1985
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay methods in a theophylline pharmacokinetic study
R L Lalonde, M B Bottorff, A B Straughn
Clinical Therapeutics
|
March 25, 1999
Use of diagnostic cluster methodology for therapeutic costing and drug surveillance of HMG-CoA reductase-inhibitor therapy
M B Bottorff, J P Yenkowsky, D G Cave
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Director (Cincinnati, Ohio)
|
October 1, 1993
Therapeutic options in the treatment of congestive heart failure. Part I
M B Bottorff
Director (Cincinnati, Ohio)
|
January 1, 1994
Therapeutic options in the treatment of congestive heart failure. Part II
M B Bottorff
Pharmacotherapy
|
April 23, 1999
Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations
M B Bottorff, D M Tenero
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1992
Advances in antiarrhythmic drug therapy
D C Harrison, M B Bottorff
Clinical Chemistry
|
September 1, 1986
Fluorescence polarization immunoassay for ethosuximide evaluated and compared with two other immunoassay techniques
C F Stewart, M B Bottorff
Clinical Pharmacokinetics
|
December 1, 1991
Pharmacokinetic interactions with calcium channel antagonists (Part II)
K D Schlanz, S A Myre, M B Bottorff
Therapeutic Drug Monitoring
|
January 1, 1989
A high-performance liquid chromatographic method for the determination of encainide and its major metabolites in urine and serum using solid-phase extraction
D J Kazierad, T J Hoon, M B Bottorff
Pharmacotherapy
|
September 1, 1985
Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties
M B Bottorff, D R Rutledge, J A Pieper
Therapeutic Drug Monitoring
|
January 1, 1985
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay methods in a theophylline pharmacokinetic study
R L Lalonde, M B Bottorff, A B Straughn
Clinical Therapeutics
|
March 25, 1999
Use of diagnostic cluster methodology for therapeutic costing and drug surveillance of HMG-CoA reductase-inhibitor therapy
M B Bottorff, J P Yenkowsky, D G Cave
Page
of 4